SAA1 can cross the BBB, promote the aggregation of brain Aβ protein, and induce an increase in the number of microglia in the brain and pro‐inflammatory factor expression levels, leading to depression‐like behavioral changes in mice [40]. Here, SAA1 is linked to depressive symptom measurement.